ZenzeTech

ZenzeTech envision a future where data and AI play a natural part of clinical decision making as a partner to caregivers and patients. We are driven by helping patients and define our success by the value we create for them. After pitching in Paris, ZenzeTech was chosen as one of 10 Life Science and Medtech startups in Europe to participate in 'Neighborhood' 2022, a one-year regulatory development program. ZenzeTech secures financing from business angels with MedTech and Life Science experience to help with advice and further development. ZenzeTech was awarded with a grant from Sportgoodsfonden for being one of three of the most promising startups in DTU Science Park with a scalable product and big potential to create an impact on patients worldwide. ZenzeTech is addressing a big problem and therefor a big market. ZenzeTech is one of the most promising startups in DTU Science Park and receives grant Written by Christian Bygballe Haahr, May 9 …. We are developing a solution for continuous home-monitoring of people with neurological diseases’ gait symptoms with non-invasive, connected insoles that give objective knowledge of the treatment’s efficacy, enabling neurologists to change it accordingly.